Mindset Pharma Reports Fiscal Year 2021 Financial Results and Provides Corporate Update

Evolving Pipeline of Psychedelics Compounds Focused on Improved Efficacy and Safety Advancing MSP-1014 as First Lead Drug Clinical Candidate to IND-Enabling Studies Developing Robust Patent Portfolio for Next-Generation Compounds and Methods — TORONTO, Oct. 26, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery […]

Mindset Pharma to Participate in Wonderland: Miami on November 8-9, 2021

TORONTO, Oct. 26, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that it will participate in Microdose’s Wonderland: Miami […]